Dabigatran
Dabigatran is a pharmaceutical drug with 81 clinical trials. Currently 6 active trials ongoing. Historical success rate of 91.2%.
Success Metrics
Based on 52 completed trials
Phase Distribution
Phase Distribution
14
Early Stage
7
Mid Stage
23
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.2%
52 of 61 finished
14.8%
9 ended early
6
trials recruiting
81
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Anticoagulation in Patients With Venous Thromboembolism and Cancer
High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France
A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects
Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.
Clinical Trials (81)
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Anticoagulation in Patients With Venous Thromboembolism and Cancer
High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France
A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects
Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.
A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France
Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volunteers
Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam
ReAHEAD: A Study to Find Out Whether Education Improves Adherence to Dabigatran in People With Atrial Fibrillation Who Are Younger Than 75 Years
A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.
The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)
Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis
PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation
Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)
A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy Participants
PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants
NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 81